What is the P/E ratio of Brabourne Enterprises . (Amalgamated)?

The latest standalone P/E ratio of Brabourne Enterprises . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Brabourne Enterprises . (Amalgamated)?

The latest standalone P/B ratio of Brabourne Enterprises . (Amalgamated) as of 01-Jan-1970 is 0.23.

What is the 52-week high and low of Brabourne Enterprises . (Amalgamated)?

The 52-week high of Brabourne Enterprises . (Amalgamated) is Rs. 10.40 and the 52-week low is Rs. 9.60.

Brabourne Enterprises Ltd. (Amalgamated) - Stock Valuation and Financial Performance

Name: Brabourne Enterprises . (Amalgamated)
Brand: Brabourne Enterprises . (Amalgamated)

BSE: 500384 | NSE: BRABOURNE | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Brabourne Enter

Based on:

Data

M-Cap below 100cr DeciZen not available

Brabourne Enterprises Ltd. (Amalgamated) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

14.6 Cr.

52-wk low:

9.6

52-wk high:

10.4

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Brabourne Enter:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	TTM
ROCE % ⓘ	8.7%	11.2%	10.4%	11.3%	1.9%	3.6%	4.4%	17.7%	9.2%	-9.4%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	186	213	181	185	107	119	124	145	121	0	0
Sales YoY Gr.	-	14.7%	-15.1%	2.1%	-42.2%	11.8%	4.1%	16.6%	-16.5%	-100%	-
Adj EPS ⓘ	4.9	8.6	7.4	3.2	-8.2	-5.3	-3.4	13.8	5.9	-7.8	-0.1
YoY Gr.	-	76.4%	-14.3%	-56.1%	-354.5%	NA	NA	NA	-57.2%	-232.4%	-
BVPS (₹) ⓘ	83.2	81.2	78.7	52.8	32.9	45.9	32.8	59.7	63.8	43.4	43.3
Adj Net Profit ⓘ	5.3	9.4	9.1	4	-10.2	-6.6	-4.2	19.8	8.5	-11.2	0
Cash Flow from Ops. ⓘ	-7.5	-11.4	0.2	20.4	39.6	32.7	22.5	44.4	15.3	0.1	-
Debt/CF from Ops. ⓘ	-12.1	-9.7	570.8	5.4	2.5	3.9	5.3	2.1	5.5	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-100%	-100%	-100%	-100%
Adj EPS ⓘ	-205.4%	NA	NA	-232.4%
BVPSⓘ	-7%	5.7%	9.8%	-31.9%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	TTM
Return on Equity % ⓘ	5.8	10.2	9.4	5.9	-18	-10.6	-8.5	30.9	9.4	-14.5	-0.1
Op. Profit Mgn % ⓘ	8.1	11.8	13.1	12.8	2.7	12.2	9.3	27.4	19.4	0	NAN
Net Profit Mgn % ⓘ	2.9	4.4	5.1	2.2	-9.6	-5.5	-3.4	13.6	7	0	-INF
Debt to Equity ⓘ	1	1.2	1.4	1.7	2.4	2.2	2.9	1.1	0.9	0	-
Working Cap Days ⓘ	0	190	274	210	361	418	381	328	391	0	0
Cash Conv. Cycle ⓘ	0	71	102	67	77	22	4	-42	-18	0	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Brabourne Enterprises Ltd. (Amalgamated)

	Standalone	Consolidated
TTM EPS (₹)	-0.1	1.4
TTM Sales (₹ Cr.)	0	6.5
BVPS (₹.) ⓘ	43.3	45.1
Reserves (₹ Cr.) ⓘ	48	50
P/BV ⓘ	0.23	0.22
PE ⓘ	0.00	7.26

From the Market
52 Week Low / High (₹)	9.60 / 10.40
All Time Low / High (₹)	4.55 / 206.95
Market Cap (₹ Cr.)	14.6
Equity (₹ Cr.)	14.4
Face Value (₹)	10
Industry PE ⓘ	48.5

Management X-Ray of Brabourne Enter:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Brabourne Enter

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Brabourne Enter

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08
Sales	186	213.29	181	277.23	160.30	119.48	124.37	145.04	121.13	0
Operating Expenses ⓘ	172.65	189.43	157.75	242.36	157.01	107.56	113.49	105.51	97.97	0.09
Manufacturing Costs	13.31	13.49	15.49	26.51	16.34	17.45	20.42	10.42	12.84	0
Material Costs	109.10	116.18	79.64	125.88	60.15	42.85	43.03	43.10	41.93	0
Employee Cost	15.87	19.11	20.49	30.95	26.92	17.80	19.56	19.38	20.57	0.01
Other Costs ⓘ	34.37	40.64	42.13	59.01	53.59	29.46	30.48	32.62	22.63	0.08
Operating Profit ⓘ	13.35	23.86	23.25	34.87	3.28	11.92	10.88	39.53	23.15	-0.09
Operating Profit Margin (%)	7.2%	11.2%	12.8%	12.6%	2.0%	10.0%	8.7%	27.3%	19.1%	-
Other Income ⓘ	12.28	10.58	14.64	14.23	7.98	5.93	6.02	3.27	2.87	0
Interest ⓘ	14.98	17.37	19.75	32.44	28.57	19.59	16.88	14.86	11.34	0
Depreciation ⓘ	5.54	6.29	7.03	10.40	6.42	7.12	4.69	5.59	4.76	0
Exceptional Items ⓘ	0	0	0	0	-15.27	0	0	0	0	-27.17
Profit Before Tax ⓘ	5.10	10.78	11.11	6.25	-39.01	-8.86	-4.67	22.36	9.92	-27.26
Tax ⓘ	0.50	2.10	2.18	0.65	-12.30	-2.08	0	2.67	1.68	2.97
Profit After Tax	4.60	8.68	8.93	5.60	-26.70	-6.78	-4.67	19.69	8.24	-30.22
PAT Margin (%)	2.5%	4.1%	4.9%	2.0%	-16.7%	-5.7%	-3.8%	13.6%	6.8%	-
Adjusted EPS (₹)	4.2	8.0	7.2	4.5	-21.5	-5.5	-3.8	13.7	5.7	-21.0
Dividend Payout Ratio (%)	52%	30%	33%	53%	0%	0%	0%	18%	26%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08
Equity and Liabilities
Shareholders Fund	91.59	92.39	101.91	104.23	66.11	57.93	41.28	85.99	91.71	62.44
Share Capital ⓘ	10.93	10.93	12.45	12.45	12.45	12.45	12.45	14.39	14.39	14.39
Reserves ⓘ	80.66	81.46	89.47	91.78	53.66	45.48	28.83	71.60	77.32	48.05
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	90.72	109.84	139.62	164.05	148.42	125.83	119.23	94.18	83.64	0
Long Term Debt	90.72	109.84	139.62	164.05	148.42	125.83	119.23	94.18	83.64	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Trade Payables	24.69	27.81	29.94	39	32.47	33.71	37.50	37.94	30.93	0.01
Others Liabilities ⓘ	15.32	15.32	18.02	16.69	6.31	6.09	8.88	18.20	9.25	0.89
Total Liabilities ⓘ	222.32	245.37	289.49	323.97	253.31	223.56	206.90	236.30	215.53	63.33
Fixed Assets
Gross Block	93.49	103.99	108.47	121.79	79.74	85.78	86.95	92.38	93.27	1.20
Accumulated Depreciation	22.54	28.60	35.31	45.51	29.63	40.04	44.69	50.27	54.68	0.43
Net Fixed Assetsⓘ	70.96	75.40	73.16	76.28	50.11	45.74	42.26	42.10	38.59	0.77
CWIP ⓘ	4.01	1.62	0.24	11.89	2.09	1.80	1.71	0.13	11.97	0
Investmentsⓘ	27.97	26.94	20.52	30.04	35.39	32.09	32.15	36.84	32.78	53
Inventories	38.96	35.88	39.58	41.20	24.72	25.50	27.79	23.34	19.27	0
Trade Receivables	35.25	55.47	64.83	71.84	34.82	24.91	22.51	25.43	24.42	0
Cash Equivalents	3.24	2.89	19.87	4.30	1.70	1.03	0.64	27.17	8.09	0.13
Others Assetsⓘ	41.94	47.17	71.29	88.43	104.47	92.50	79.85	81.28	80.41	9.43
Total Assets ⓘ	222.32	245.37	289.49	323.97	253.31	223.56	206.90	236.30	215.53	63.33

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08
Cash Flow From Operating Activity ⓘ	-7.51	-11.35	0.24	30.62	59.39	32.66	22.49	44.38	15.33	0.12
PBT ⓘ	5.10	10.78	11.11	6.25	-20.90	-8.86	-4.67	22.36	9.92	-27.26
Adjustment ⓘ	18.16	17.74	25.43	43.22	35.91	27.39	22.48	22.65	15.09	27.17
Changes in Working Capital ⓘ	-13.7	-16.9	-33.03	-17.75	47.23	13.53	8.72	4.46	-9.44	0.26
Tax Paid ⓘ	-2.14	-5.62	0	-1.11	0	0.60	-4.04	-5.09	-0.24	-0.05
Cash Flow From Investing Activity ⓘ	-6.45	-4.72	6.08	-36.08	-12.28	9.20	1.35	-9.22	-8.21	0
Capex	-11.27	-8.87	-3.98	-24.10	25.55	1.95	-1.33	-4.52	-13.23	0
Net Investments	0	1.03	6.42	-9.52	-10.48	1.07	-0.05	-4.72	4.07	0
Others ⓘ	4.82	3.12	3.64	-2.46	-27.36	6.18	2.73	0.02	0.96	0
Cash Flow From Financing Activityⓘ	14.48	15.73	12.19	-10.10	-49.75	-41.62	-24.21	-8.54	-26.21	-2.52
Net Proceeds from Shares ⓘ	0.43	0.19	3.60	0	0	0	0	30.65	0	0
Net Proceeds from Borrowing ⓘ	15.35	2.88	6.19	6.99	17.05	-16.38	-13.61	-24.56	-19.20	0
Interest Paid ⓘ	0	0	-19.53	-31.37	-28.88	-20.59	-16.22	-16.01	-12.95	0
Dividend Paid ⓘ	-2.31	-2.38	-2.69	-2.87	-3.02	0	0	0	-3.59	-2.16
Others ⓘ	1	15.05	24.61	17.16	-34.90	-4.64	5.62	1.38	9.53	-0.37
Net Cash Flow ⓘ	0.51	-0.33	18.51	-15.56	-2.64	0.24	-0.37	26.62	-19.09	-2.40

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08
Ratios
ROE (%)	5.07	9.68	9.58	5.71	-33.43	-11.46	-9.54	31.11	9.29	-39.22
ROCE (%)	11.06	14.81	14.15	15.48	-4.42	5.46	7.12	21.83	11.9	-22.83
Asset Turnover Ratio	0.95	1.03	0.76	1.04	0.62	0.55	0.63	0.72	0.58	0
PAT to CFO Conversion(x)	-1.63	-1.31	0.03	5.47	N/A	N/A	N/A	2.25	1.86	N/A
Working Capital Days
Receivable Days	61	69	108	78	109	83	64	55	70	0
Inventory Days	67	57	68	46	67	70	72	59	60	0
Payable Days	83	77	122	95	205	274	294	307	288	0

Brabourne Enterprises Ltd. (Amalgamated) Stock News

Brabourne Enterprises Ltd. (Amalgamated) FAQs

What is the share price of Brabourne Enter?

Company share prices are keep on changing according to the market conditions. The closing price of Brabourne Enter on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Brabourne Enter?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Brabourne Enter stood at ₹14.58.

What is the P/E ratio of Brabourne Enter?

The latest P/E ratio of Brabourne Enter as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Brabourne Enter?

The latest P/B ratio of Brabourne Enter as of 01-Jan-1970 05:30 is 0.23.

What is the 52-week high and low of Brabourne Enter?

The 52-week high of Brabourne Enter is ₹10.40 and the 52-week low is ₹9.60.

What is the TTM revenue of Brabourne Enter?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Brabourne Enter is ₹0.00 ( Cr.) .

About Brabourne Enterprises Ltd. (Amalgamated)

Brabourne Enterprises Ltd the demerged arm of RPG life was incorporated on May 12, 1967. The entire pharmaceuticals business of the Company has been sold to RPG Life Sciences Ltd. (formerly RPG Pharmaceuticals Ltd.) with effect from April 2, 2007 on going concern basis along with all assets and liabilities pertaining to the said business, at consideration of Rs. 46 crore. Thus, the results and revenue of the pharmaceutical business from April 2, 2007 has become revenue and results of RPG Pharmaceuticals Ltd. The unaudited financial results of the company for 9 months ended December 31, 2007, which pertains to the pharmaceutical business. The Group operates in two segments, namely, Pharmaceuticals and Investments and lending.

The entire Investments held by the company (excluding US 64 bonds) stands sold to Instant Holdings Ltd effective from April 1, 2007, at a consideration of Rs 53 crore. Instant Trading and Investment Company Ltd is a wholly owned subsidiary of RPG Life Sciences Ltd. RPG Pharmaceuticals Ltd and Instant Holdings Ltd were incorporated on March 29, 2007 to participate in the Scheme of Arrangement.

The assets and liabilities of the Instant Trading and Investment Company Ltd were transferred to Instant Holdings Ltd and Instant Trading and Investment Company Ltd stands dissolved without winding up. Then only the company changed its name to â€˜Brabourne Enterprises Ltdâ€™ and RPG Pharmaceuticals Ltd changed its name to â€˜RPG Life Sciences Ltdâ€™.

The plants of Brabourne Enterprises are located at Gujarat and Maharashtra.

Business area of the company:

The Company is engaged in manufacture of active pharmaceutical ingredients, both synthetic and fermentation, contract API and formulation development business with a niche product portfolio, both in chronic and acute therapy areas.